CUE: Cue Biopharma Inc
CUE exchange rate has changed by 7.14% for today. During the day, the instrument was traded at a low of 0.28 and at a high of 0.31.
Follow Cue Biopharma Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CUE News
- Cue Biopharma prices $10 million public offering at $0.28 per share
- Cue Biopharma stock tumbles on public offering announcement
- Cue Biopharma launches public offering of common stock and warrants
- Cue Biopharma stock rating reiterated at Market Outperform by Citizens
- ImmunoScape licenses Cue Biopharma technology for novel cancer therapy
- Cue Biopharma earnings beat by $0.02, revenue fell short of estimates
- Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Lags Revenue Estimates
- CervoMed Inc. (CRVO) Reports Q3 Loss, Misses Revenue Estimates
- Puma Biotech (PBYI) Q3 Earnings and Revenues Top Estimates
- Cue Biopharma and ImmunoScape partner on novel cancer therapy
- Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Beats Revenue Estimates
- Insmed (INSM) Reports Q3 Loss, Beats Revenue Estimates
- Cue Biopharma stock adds to gains after Nobel Prize validates CUE-401 approach
- Cue Biopharma names Usman Azam as new CEO, shifts focus to autoimmune disease
- Cue Biopharma at Cantor Conference: Strategic Focus on T-Cell Modulation
- Cue Biopharma stock initiated with Buy rating at Lucid Capital Markets
- Cue Biopharma earnings beat by $0.05, revenue topped estimates
- Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates
- Y-mAbs Therapeutics, Inc. (YMAB) Reports Q2 Loss, Tops Revenue Estimates
- scPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Lags Revenue Estimates
- Cue Biopharma reports promising results for HPV+ head and neck cancer drug
- Citizens JMP highlights key ASCO presentations
- Cue Biopharma, Inc. (CUE) Business Update Call (Transcript)
- What's Going On With Cue Biopharma Shares Tuesday? - Cue Biopharma (NASDAQ:CUE)
Frequently Asked Questions
What is CUE stock price today?
Cue Biopharma Inc stock is priced at 0.30 today. It trades within 0.28 - 0.31, yesterday's close was 0.28, and trading volume reached 686. The live price chart of CUE shows these updates.
Does Cue Biopharma Inc stock pay dividends?
Cue Biopharma Inc is currently valued at 0.30. Dividend policy depends on the company, while investors also watch -78.42% and USD. View the chart live to track CUE movements.
How to buy CUE stock?
You can buy Cue Biopharma Inc shares at the current price of 0.30. Orders are usually placed near 0.30 or 0.60, while 686 and 7.14% show market activity. Follow CUE updates on the live chart today.
How to invest into CUE stock?
Investing in Cue Biopharma Inc involves considering the yearly range 0.23 - 1.53 and current price 0.30. Many compare -3.23% and -60.00% before placing orders at 0.30 or 0.60. Explore the CUE price chart live with daily changes.
What are Cue Biopharma Inc stock highest prices?
The highest price of Cue Biopharma Inc in the past year was 1.53. Within 0.23 - 1.53, the stock fluctuated notably, and comparing with 0.28 helps spot resistance levels. Track Cue Biopharma Inc performance using the live chart.
What are Cue Biopharma Inc stock lowest prices?
The lowest price of Cue Biopharma Inc (CUE) over the year was 0.23. Comparing it with the current 0.30 and 0.23 - 1.53 shows potential long-term entry points. Watch CUE moves on the chart live for more details.
When did CUE stock split?
Cue Biopharma Inc has gone through stock splits historically. These changes are visible in , 0.28, and -78.42% after corporate actions.
- Previous Close
- 0.28
- Open
- 0.28
- Bid
- 0.30
- Ask
- 0.60
- Low
- 0.28
- High
- 0.31
- Volume
- 686
- Daily Change
- 7.14%
- Month Change
- -3.23%
- 6 Months Change
- -60.00%
- Year Change
- -78.42%
- Act
- Fcst
- Prev